Military study probes Toxins' role in lymphoma

NCT ID NCT07652580

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This observational study is recruiting 300 active-duty service members and military beneficiaries diagnosed with B-cell non-Hodgkin lymphoma. Researchers want to understand how exposure to toxins, genetic differences, and immune system problems are linked to this cancer. Participants will fill out surveys, give blood or skin samples, and may be followed for up to three years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this research could identify specific toxins or genetic factors linked to B-cell NHL, potentially guiding future prevention or early detection strategies.
What could go wrong
This is an observational study, not a treatment trial. It may not find clear links, and results may not apply to non-military populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for B CELL LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Naval Medical Center Portsmouth

    ACTIVE_NOT_RECRUITING

    Portsmouth, Virginia, 23708, United States

  • Uniformed Services University of the Health Sciences

    ACTIVE_NOT_RECRUITING

    Bethesda, Maryland, 20814, United States

  • Walter Reed National Military Medical Center

    RECRUITING

    Bethesda, Maryland, 20814, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.